Iraq Proposes Clean Energy Investments to BP, Total

A view shows Iraq's Majnoon oil field near Basra, Iraq, March 27, 2022. (Reuters)
A view shows Iraq's Majnoon oil field near Basra, Iraq, March 27, 2022. (Reuters)
TT

Iraq Proposes Clean Energy Investments to BP, Total

A view shows Iraq's Majnoon oil field near Basra, Iraq, March 27, 2022. (Reuters)
A view shows Iraq's Majnoon oil field near Basra, Iraq, March 27, 2022. (Reuters)

Iraq’s Oil Minister Ihsan Abdul Jabbar held talks in London and Paris with the chief executive officers of the British Petroleum company and France’s Total and officials from the French ministries of economy and energy.

He proposed new plans to invest in the oil, gas and clean energy sectors, a ministry statement revealed on Saturday.

Abdul Jabbar said during his meeting with CEO of BP Bernard Lonnie that Iraq boasts many plans and projects in the field of clean energy.

The minister said Iraq has concluded various agreements with Norway's Scatec, France’s Total, China’s Power China, UAE’s Masdar and Saudi Arabia’s ACWA Power to implement renewable energy projects.

Baghdad plans to produce 20% of its energy production from renewable and clean energy, Abdul Jabbar said, adding that it is working to create a good environment for investment and all the efforts are directed to implement these plans.

Commenting on his meeting with CEO of TotalEnergies Patrick Pouyanee in Paris, he stated they discussed programs, job opportunities and joint cooperation to implement projects in the fields of oil and energy.

They also agreed on the timing of implementing joint projects, such as the Gas Investment Project in a number of oil fields in southern Iraq, the Solar Energy Project, Artawi Field Development Project to increase its output, as well as the Common Seawater Supply Project to support sustained and increased production in oilfields.

Abdul Jabbar further discussed with the two French ministries his country’s potentials in gas production, especially after it completed the development of the free gas fields in the Anbar and Diyala provinces.

Talks also touched on the investment of gas associated with oil operations, and the possibility of boosting production with an eye on international energy security.

The minister said he is coordinating with producers to achieve balance and required stability in global markets.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.